Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 535

1.

Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera.

Silver RT, Krichevsky S, Gjoni S, Cross NC.

Leuk Lymphoma. 2017 Mar 20:1-2. doi: 10.1080/10428194.2017.1300892. [Epub ahead of print] No abstract available.

PMID:
28317411
2.

Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia.

Gunawan AS, McLornan DP, Wilkins B, Waghorn K, Hoade Y, Cross NC, Harrison CN.

Haematologica. 2017 Mar 16. pii: haematol.2017.163790. doi: 10.3324/haematol.2017.163790. [Epub ahead of print] No abstract available.

3.

Genomics of Myeloproliferative Neoplasms.

Zoi K, Cross NC.

J Clin Oncol. 2017 Mar 20;35(9):947-954. doi: 10.1200/JCO.2016.70.7968.

PMID:
28297629
4.

Measurement of BCR-ABL1 by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme.

Scott S, Travis D, Whitby L, Bainbridge J, Cross NC, Barnett D.

Br J Haematol. 2017 Mar 14. doi: 10.1111/bjh.14557. [Epub ahead of print]

PMID:
28295199
5.

The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm.

Jawhar M, Schwaab J, Meggendorfer M, Naumann N, Horny HP, Sotlar K, Haferlach T, Schmitt K, Fabarius A, Valent P, Hofmann WK, Cross NC, Metzgeroth G, Reiter A.

Haematologica. 2017 Mar 2. pii: haematol.2017.163964. doi: 10.3324/haematol.2017.163964. [Epub ahead of print]

6.

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.

Hochhaus A, Mahon FX, le Coutre P, Petrov L, Janssen JJ, Cross NC, Rea D, Castagnetti F, Hellmann A, Rosti G, Gattermann N, Coronel ML, Gutierrez MA, Garcia-Gutierrez V, Vincenzi B, Dezzani L, Giles FJ.

J Cancer Res Clin Oncol. 2017 Feb 21. doi: 10.1007/s00432-017-2359-9. [Epub ahead of print]

PMID:
28224300
7.

Longitudinal changes in quality of life following ICD implant and the impact of age, gender, and ICD shocks: observations from the INTRINSIC RV trial.

Gopinathannair R, Lerew DR, Cross NJ, Sears SF, Brown S, Olshansky B.

J Interv Card Electrophysiol. 2017 Apr;48(3):291-298. doi: 10.1007/s10840-017-0233-y. Epub 2017 Feb 20.

PMID:
28220279
8.

P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5.

Galaway F, Drought LG, Fala M, Cross N, Kemp AC, Rayner JC, Wright GJ.

Nat Commun. 2017 Feb 10;8:14333. doi: 10.1038/ncomms14333.

9.

Functional Connectivity in the Default Mode Network is Reduced in Association with Nocturnal Awakening in Mild Cognitive Impairment.

McKinnon AC, Duffy SL, Cross NE, Terpening Z, Grunstein RR, Lagopoulos J, Batchelor J, Hickie IB, Lewis SJ, Shine JM, Naismith SL.

J Alzheimers Dis. 2017;56(4):1373-1384. doi: 10.3233/JAD-160922.

PMID:
28157095
10.

Beliefs and Attitudes to Bowel Cancer Screening in Patients with CKD: A Semistructured Interview Study.

James LJ, Wong G, Craig JC, Ju A, Williams N, Lim WH, Cross N, Tong A.

Clin J Am Soc Nephrol. 2017 Feb 2. pii: 10090916. doi: 10.2215/CJN.10090916. [Epub ahead of print]

PMID:
28153937
11.

Guideline for the investigation and management of eosinophilia.

Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, Ewing J, Harrison CN, Knapper S, McLornan D, Mead AJ, Radia D, Bain BJ; British Committee for Standards in Haematology..

Br J Haematol. 2017 Feb;176(4):553-572. doi: 10.1111/bjh.14488. No abstract available.

PMID:
28112388
12.

Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.

Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC.

Cochrane Database Syst Rev. 2017 Jan 11;1:CD004759. doi: 10.1002/14651858.CD004759.pub2. Review.

PMID:
28073178
13.

Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators.

Ruiz MS, Medina M, Tapia I, Mordoh J, Cross NC, Larripa I, Bianchini M.

Leukemia. 2016 Nov;30(11):2258-2260. doi: 10.1038/leu.2016.197. No abstract available.

14.

Biological and structural studies of phosphonium 'masked thiolate' compounds.

Chen YS, Allen DW, Tizzard GJ, Pitak MB, Coles SJ, Cross NA, Bricklebank N.

Eur J Med Chem. 2017 Jan 5;125:528-537. doi: 10.1016/j.ejmech.2016.08.025.

15.

A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis.

Wright DF, Doogue MP, Barclay ML, Chapman PT, Cross NB, Irvine JH, Stamp LK.

Eur J Clin Pharmacol. 2017 Jan;73(1):71-78. doi: 10.1007/s00228-016-2133-y.

PMID:
27683090
16.

Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones ("Bath Salts") in Recreational Users.

Ashrafioun L, Bonadio FA, Baik KD, Bradbury SL, Carhart VL, Cross NA, Davis AK, Feuille M, Harper AR, Lackey JH, Lang B, Lauritsen KJ, Leith J, Osborn LA, Rosenberg H, Stock J, Zaturenskaya M.

J Psychoactive Drugs. 2016 Nov-Dec;48(5):336-343.

PMID:
27681583
17.

A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens.

Drew DR, Wilson DW, Elliott SR, Cross N, Terheggen U, Hodder AN, Siba PM, Chelimo K, Dent AE, Kazura JW, Mueller I, Beeson JG.

BMC Med. 2016 Sep 23;14(1):144.

18.

Antisense Oligonucleotides Modulating Activation of a Nonsense-Mediated RNA Decay Switch Exon in the ATM Gene.

Kralovicova J, Moreno PM, Cross NC, Pêgo AP, Vorechovsky I.

Nucleic Acid Ther. 2016 Dec;26(6):392-400.

19.

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.

Jawhar M, Schwaab J, Hausmann D, Clemens J, Naumann N, Henzler T, Horny HP, Sotlar K, Schoenberg SO, Cross NC, Fabarius A, Hofmann WK, Valent P, Metzgeroth G, Reiter A.

Leukemia. 2016 Dec;30(12):2342-2350. doi: 10.1038/leu.2016.190.

PMID:
27416984
20.

Tailoring Vacancies Far Beyond Intrinsic Levels Changes the Carrier Type and Optical Response in Monolayer MoSe2-x Crystals.

Mahjouri-Samani M, Liang L, Oyedele A, Kim YS, Tian M, Cross N, Wang K, Lin MW, Boulesbaa A, Rouleau CM, Puretzky AA, Xiao K, Yoon M, Eres G, Duscher G, Sumpter BG, Geohegan DB.

Nano Lett. 2016 Aug 10;16(8):5213-20. doi: 10.1021/acs.nanolett.6b02263.

PMID:
27416103

Supplemental Content

Loading ...
Support Center